COVID-19
| 3 min read
Researchers designed a nanoparticle that inactivated a wide range of COVID-19 strains, potentially offering a broad-spectrum therapeutic approach.
| 6 min read
Viral diseases like hepatitis don’t have many successful treatments available, so scientists are engineering antibodies to try and change that.
| 6 min read
Pioneering approaches transform vaccine technologies and shape the future of disease prevention.
| 8 min read
Pathogens invade mucosal surfaces like the nose, but typical vaccines don't mount an immune response there. Newly engineered mucosal vaccines, however, do.
| 4 min read
| 5 min read
Katalin Karikó and Drew Weissman received this year’s Physiology or Medicine award for their work on RNA biology and mRNA-based vaccines.
| 4 min read
Robert Georgantas aims to expand the development of mRNA-based vaccines for a range of infectious diseases and cancers.
| 1 min read
Researchers discovered how SARS-CoV-2 invades and spreads through nasal epithelial cells, identifying potential new drug targets to prevent transmission.
| 9 min read
The success of vaccines and cancer treatments varies depending on the time of day they are delivered. Researchers now look to exploit circadian rhythms to improve health outcomes.
| 2 min read
In writing about new pain treatments that could benefit a family member, I was reminded of the real people behind every study and story.
